在炎症性肠道疾病的治疗中使用ustekinumab:演变的范式
Giammarco Mocci1, Antonio Tursi2,3, Francesca Maria Onidi1
1Division of Gastroenterology, "Brotzu" Hospital, 09124 Cagliari, Italy.
Journal of clinical medicine
|April 9, 2024
概括
乌斯特基努马布 (UST) 有效治疗克罗恩氏病和性结肠炎,在临床试验和现实世界的数据中显示出积极的结果. 这次审查涵盖了UST.
科学领域:
- 胃肠道学和免疫学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是慢性免疫媒介疾病.
- 乌斯特基努马布 (UST) 是一种抗联素-12/23单克隆抗体,向IBD的关键炎症途径.
研究的目的:
- 审查乌斯特基努马布 (UST) 对炎症性肠病 (IBD) 的疗效和安全性.
- 综合从关键试验,现实世界的证据,和新兴的研究在CD和UC中UST的数据.
主要方法:
- 审查关键的临床试验 (例如,CERTIFI,UNITI-IM,UNIFI) 对于在CD和UC中进行UST.
- 分析现实世界的数据和最近的对比试验,比较UST与TNF抗剂.
- 包括关于特定临床情景的研究和治疗药物监测.
主要成果:
- UST在诱导和维持CD和UC的缓解方面表现出有效性,特别是在以前没有服用生物药物的患者中.
- 现实世界的数据支持积极的临床,内镜和组织学结果,对UST有有利的安全性.
- 新出现的数据涉及特定的应用,如围性CD,囊炎,怀孕和免疫性.
结论:
- 乌斯特基努马布是适度至重症CD和UC的有效治疗选择.
- 目前正在进行的研究和现实世界的证据继续完善对UST在IBD管理中的作用和最佳使用的理解.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
136
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
136
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
161
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
161
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331


